QT prolongation and syncope with methadone, doxepin, and a beta-blocker.
Rademacher
Sibylle
S
Dietz
Rainer
R
Haverkamp
Wilhelm
W
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D001008:Anxiety Disorders / Q000150:complications / Q000188:drug therapy; D004316:Doxepin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004562:Electrocardiography; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D008297:Male; D008691:Methadone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D019966:Substance-Related Disorders / Q000150:complications / Q000534:rehabilitation; D013575:Syncope / Q000139:chemically induced*; D013610:Tachycardia / Q000150:complications / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D004316:Doxepin; D008691:Methadone